Open original FDA record ↗Recall record
- FDA identifier
- Z-1123-2022
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- May 23, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Implantable Neurostimulator Model may be susceptible to not communicating with the clinical programmer and/or patient programmer system.
Source facts
- Action
- A customer letter, dated March 2022, was issued to the impacted consignee via mail. The consignee is instructed to ensure the patient programmer system is paired with the patient's INS. If the INS cannot communicate with the clinician programmer and/or patient programmer system, and it is not possible to make therapy adjustments, the consignee is to contact Medtronic Technical Services. The consignee is also asked to complete the customer confirmation form and submit to the recalling firm. Medtronic will be notifying consignees and actively retrieving any unused Vanta INS devices that contain the previous firmware version (as of 03-December-2025). Consignees will be asked to sign and return a confirmation form if applicable by region.
- Initiated
- 2022-03-30
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, ND, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY and the countries of Italy, Sweden, Netherlands, Belgium, United Kingdom, Japan, Finland, Portugal, Spain, Canary Islands, Denmark, Germany, Switzerland, Ireland, Croatia, Norway.
- Recall number
- Z-1123-2022
- Recall status
- Open, Classified
- CDRH record ID
- 193012
- FDA classified
- 2022-05-23
- Recall event number
- 89971